Prognostic significance of hypoxia-inducible factor 1 alpha(HIF-1alpha) expression in serous ovarian cancer: An immunohistochemical study

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Daponte, Alexandros ^a   Ioannou, Maria ^a   Mylonis, Ilias ^b   Simos, George ^b   Minas, Marcos ^a   Messinis, Ioannis E ^a   Koukoulis, George ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HIF1A PROTEIN, HUMAN;

ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; CYSTADENOCARCINOMA; FEMALE; GYNECOLOGIC SURGERY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; PROGNOSIS; PROTEIN EXPRESSION; RISK ASSESSMENT; SURVIVAL TIME; CANCER STAGING; GENE EXPRESSION; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY; SURVIVAL;

FEMALE; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL;

EID: 62349084794     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-335     Document Type: Article

References (33)

1. Semenza GL Regulation of mammalian O2 homeostasis by hypoxia inducible factor 1 Annu Rev Cell Dev Biol 1999, 15:551-78 10611972
2. Semenza GL Targeting HIF-1 for cancer therapy Nat Rev Cancer 2003, 3:721-32 13130303
3. Semenza GL Targeting HIF-1 for cancer therapy Nat Rev Cancer 2003, 3:721-32 13130303
4. Melillo G Inhibiting hypoxia-inducible factor 1 for cancer therapy Mol Cancer Res 2006, 4:601-5 16940159
5. Zhong H De Marzo AM Laughner E Lim M Hilton DA Zagzag D Buechler P Isaacs WB Semenza GL Simons JW Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases Cancer Res 1999, 59:5830-5835 10582706
6. Birner P M Schindle A Obermair G Breitenecker G Oberhuber G Expression of hypoxia-inducible factor 1 alpha in epithelial ovarian tumors: Its impact on prognosis and on response to chemotherapy Clin Cancer Res 2001, 7:1661-1668 11410504
7. Wong C Wellman TL Lounsbury KM VEGF and HIF-1alpha expression are increased in advanced stages of epithelial ovarian cancer Gynecol Oncol 2003, 91:513-517 14675669
8. Nakayama K A Kanzaki K Hata H Katabuchi H Okamura K Miyazaki M Fukumoto Y Takebayashi Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma Cancer Lett 2002, 176:215-223 11804750
9. Nakai H Watanabe Y Ueda H Hoshiai H Hypoxia inducible factor 1-alpha expression as a factor predictive of efficacy of taxane/platinum chemotherapy in advanced primary epithelial ovarian cancer Cancer Lett 2007, 251(1):164-7 17215078
10. Osada R Horiuchi A Kikuchi N Yoshida J Hayashi A Ota M Katsuyama Y Mellilo G Konishi I Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma Hum Pathol 2007, 38(9):1310-20 17555795
11. Lyberopoulou A Venieris E Mylonis I Chachami G Pappas I Simos G Bonanou S Georgatsou E MgcRacGAP interacts with HIF-1alpha and regulates its transcriptional activity Cell Physiol Biochem 2007, 20:995-1006 17982282
12. Shott S Statistics for health professionals W.B. SAUNDERS, London 1990 10
13. Beasley NJ Leek R Alam M Turley H Cox GJ Gatter K Millard P Fuggle S Harris AL Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: Relationship to tumor biology and treatment outcome in surgically resected patients Cancer Res 2002, 62:2493-7 11980639
14. Koukourakis MI Bentzen SM Giatromanolaki A Wilson GD Daley FM Saunders MI Dische S Sivridis E Harris AL Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial J Clin Oncol 2006, 24:727-35 16418497
15. Generali D Berruti A Brizzi MP Campo L Bonardi S Wigfield S Bersiga A Allevi G Milani M Aguggini S Gandolfi V Dogliotti L Bottini A Harris AL Fox SB Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer Clin Cancer Res 2006, 12:4562-8 16899602
16. Shannon AM Bouchier-Hayes DJ Condron CM Toomey D Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies Cancer Treat Rev 2003, 29:297-307 12927570
17. Wenger RH Stiehl DP Camenisch G Integration of oxygen signaling at the consensus HRE Sci STKE 2005, 306:rE12 2005 Oct 18 16234508
18. Wenger RH Mitochondria: Oxygen sinks rather than sensors? Med Hypotheses 2006, 66:380-383 16229963
19. Escuin D Kline ER Giannakakou P Both microtubulestabilizing and micro tubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function Cancer Res 2005, 65:9021-9028 16204076
20. Kallio PJ Okamoto K O'Brien S Carrero P Makino Y Tanaka H Poellinger L Signal transduction in hypoxic cells: Inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha EMBO J 1998, 17:6573-6586 1171004 9822602
21. Y Chun YS Choi E Kim TY Kim MS Park JW A dominant-negative isoform lacking exons 11 and 12 of the human hypoxia-inducible factor-1alpha gene Biochem J 2002, 362:71-79 1222361 11829741
22. Koukourakis MI Giatromanolaki A Skarlatos J Corti L Blandamura S Piazza M Gatter KC Harris AL Hypoxia inducible factor (HIF-1α and HIF-2α) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy Cancer Res 2001, 61:1830-1832 11280732
23. Talks KL Turley H Gatter KC Maxwell PH Pugh CW Ratcliffe PJ Harris AL The expression and distribution of the hypoxia inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages Am J Pathol 2000, 157:411-421 1850121 10934146
24. Zagzag D Zhong H Scalzitti JM Laughner E Simons JW Semenza GL Expression of hypoxia-inducible factor 1alpha in brain tumors: Association with angiogenesis, invasion, and progression Cancer 2000, 88:2606-2618 10861440
25. Mylonis I Chachami G Samiotaki M Panayotou G Paraskeva E Kalousi A Georgatsou E Bonanou S Simos G Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha J Biol Chem 2006, 281:33095-106 16954218
26. Rapisarda A Shoemaker RH Melillo G Targeting topoisomerase I to inhibit hypoxia inducible factor 1 Cell Cycle 2004, 3(2):172-5 Review 14712084
27. Mabjeesh NJ Escuin D LaVallee TM Pribluda VS Swartz GM Johnson MS Willard MT Zhong H Simons JW Giannakakou P 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF Cancer Cell 2003, 3(4):363-75 12726862
28. Ricker JL Chen Z Yang XP Pribluda VS Swartz GM Van Waes C 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma Clin Cancer Res 10(24):8665-73 2004 Dec 15 15623651
29. Neckers L Chaperoning oncogenes: Hsp90 as a target of geldanamycin Handb Exp Pharmacol 2006, 172:259-77 16610363
30. Neckers L Using natural product inhibitors to validate Hsp90 as a molecular target in cancer Curr Top Med Chem 2006, 6(11):1163-71 16842153
31. Jiang H Feng Y Hypoxia-inducible factor 1alpha (HIF-1alpha) correlated with tumor growth and apoptosis in ovarian cancer Int J Gynecol Cancer 2006, 1:405-412 16515634
32. Mabuchi S Altomare DA Connolly DC Klein-Szanto A Litwin S Hoelzle MK Hensley HH Hamilton TC Testa JR RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer Cancer Res 2007, 67:2408-2413 17363557
33. Treek O Wackwitz B Haus U Ortmann O Effects of a combined treatment with mTOR inhibitor RAD001 and tamoxifen in vitro on growth and apoptosis of human cancer cells Gynecol Oncol 2006, 102:292-299 16443261